Off-patent Drug Library

(2,674) Cat. No.: HY-L141: Library Contents: XLSX PDF

Drug repurposing (also called drug repositioning, reprofiling, or re‑tasking) offers various advantages over developing an entirely new drug for a given indication, for example, lower risk of failure, less investment, and shorter development timelines. But drug repositioning projects are also subject to several risks, including regulatory and intellectual property issues. So the off-patent drugs are optimal for repositioning because of their immediate availability for clinical studies, with high feasibility and relatively low risk.

MCE carefully prepared a unique collection of 2,674 off-patent drugs, which is a good choice for drug repurposing.

Size (Pre-dissolved DMSO or Solid)	Price	Stock
30 μL/well (10 mM solution)	Get quote	In-stock
50 μL/well (10 mM solution)	Get quote	In-stock
100 μL/well (10 mM solution)	Get quote	In-stock
250 μL/well (10 mM solution)	Get quote	In-stock

Download Screening Library Catalog

Please contact us at

sales@MedChemExpress.com

Off-patent Drug Library

Customer Validation